Evidence map›Paper›PMID 34957083›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Dual-Use Quickscan: A Web-Based Tool to Assess the Dual-Use Potential of Life Science Research.

Iris M Vennis, Mirjam M Schaap, Petra A M Hogervorst, Arnout de Bruin, Sjors Schulpen, Marijke A Boot, Mark W J van Passel, Saskia A Rutjes, Diederik A Bleijs

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Unmet Expectations: Life Scientists' Views on Biorisk and Responsibility.Applied biosafety : journal of the American Biological Safety Association · 2025
    Article
  2. Article
  3. Mapping variation in dual use risk assessments of synthetic biology projects.Frontiers in bioengineering and biotechnology · 2025
    Article
  4. Review
  5. Socially responsible science: Exploring the complexities.European journal for philosophy of science · 2023
    Article
  6. Biosafety and biosecurity challenges during the COVID-19 pandemic and beyond.Frontiers in bioengineering and biotechnology · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Iris M VennisBiosecurity Office, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Mirjam M SchaapBiosecurity Office, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Petra A M HogervorstBiosecurity Office, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Arnout de BruinBiosecurity Office, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Sjors SchulpenBiosecurity Office, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Marijke A BootBiosecurity Office, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Mark W J van PasselBiosecurity Office, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Saskia A RutjesBiosecurity Office, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Diederik A BleijsBiosecurity Office, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
National Institute for Public Health and the Environment · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research on pathogenic organisms is crucial for medical, biological and agricultural developments. However, biological agents as well as associated knowledge and techniques, can also be misused, for example for the development of biological weapons. Potential malicious use of well-intended research, referred to as "dual-use research", poses a threat to public health and the environment. There are various international resources providing frameworks to assess dual-use potential of the research concerned. However, concrete instructions for researchers on how to perform a dual-use risk assessment is largely lacking. The international need for practical dual-use monitoring and risk assessment instructions, in addition to the need to raise awareness among scientists about potential dual-use aspects of their research has been identified over the last years by the Netherlands Biosecurity Office, through consulting national and international biorisk stakeholders. We identified that Biorisk Management Advisors and researchers need a practical tool to facilitate a dual-use assessment on their specific research. Therefore, the Netherlands Biosecurity Office developed a web-based Dual-Use Quickscan (www.dualusequickscan.com), that can be used periodically by researchers working with microorganisms to assess potential dual-use risks of their research by answering a set of fifteen yes/no questions. The questions for the tool were extracted from existing international open resources, and categorized into three themes: characteristics of the biological agent, knowledge and technology about the biological agent, and consequences of misuse. The results of the Quickscan provide the researcher with an indication of the dual-use potential of the research and can be used as a basis for further discussions with a Biorisk Management Advisor. The Dual-Use Quickscan can be embedded in a broader system of biosafety and biosecurity that includes dual-use monitoring and awareness within organizations. Increased international attention to examine pathogens with pandemic potential has been enhanced by the current COVID-19 pandemic, hence monitoring of dual-use potential urgently needs to be encouraged.

Indexed as

assessment toolbiorisk managementbiosafetybiosecuritydual-use research of concernhigh-risk pathogensinternational health regulationsmisuse

Identifiers

PMID34957083
PMCPMC8696162
OpenAlexW4200462442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.